Getinge AB (GNGBF) Q2 2025 Earnings Call Highlights: Strong Organic Growth and Margin ...
Order Intake Growth: 4.4% organically.
Recurring Revenue: 65% of total sales.
High Margin Products: Comprise about 2/3 of sales.
Adjusted Gross Profit: SEK4.183 billion.
Gross Margin Increase: Up by 0.8 percentage points.
Adjusted EBITDA: SEK989 million, margin improved by 0.2 percentage points to 12%.
Tariff Costs: Approximately SEK110 million in Q2.
Free Cash Flow: SEK0.5 billion in Q2.
Net Debt: SEK11.7 billion, leverage at 1.7 times adjusted EBITDA.
Cash Position: Approximately SEK1.9 billion at the end of Q2.
2025 Outlook: Organic net sales growth expected to be 2% to 5%.
Warning! GuruFocus has detected 6 Warning Signs with GNGBF.
Release Date: July 18, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
Getinge AB (GNGBF) reported a solid quarter with net sales growing by 4.1% organically, driven by positive development across all business areas and regions.
The company achieved a significant increase in sales from recurring revenue, now at 65%, and high-margin products make up about two-thirds of sales.
Adjusted gross and EBITDA margins improved due to acquisitions, healthy price increases, and a positive mix, despite tariffs and currency headwinds.
The financial position remains strong with financial leverage well below 2.5 times EBITDA, even after the acquisition of Paragonix.
Getinge AB (GNGBF) continues to invest in new products and solutions, such as the Servo-c ventilator with neonatal options and the Zen disinfection chemistry portfolio, enhancing its market offerings.
Negative Points
Tariffs and currency fluctuations negatively impacted the EBITDA margin, with tariffs costing approximately SEK110 million in the second quarter.
The Life Science segment experienced softer performance due to high comparative figures from the previous year.
There are ongoing elevated costs related to quality improvements, particularly in the balloon pump and cardiopulmonary categories.
The company faces challenges in maintaining market share in certain categories, such as intra-aortic balloon pumps, due to restrictions on actively selling and marketing these products.
Despite positive trends, the company anticipates more difficult comparisons in the second half of the year, particularly in ventilator sales.
Q & A Highlights
Q: Can you explain the implications of tariffs and FX on your long-term guidance and whether you've found new mitigation strategies? A: Our long-term guidance is based on the current tariff situation. We haven't found new mitigation strategies but are utilizing existing productivity improvements and regional supply chain strategies. The impact of tariffs and FX is significant, but we are managing it within our existing frameworks. - Mattias Perjos, CEO
Q: What are your current assumptions regarding EU tariffs, and how do you expect them to impact your full-year results? A: We currently assume a 10% EU tariff for the full year. If tariffs increase, we would need to recalibrate our calculations. We don't provide specific guidance on future tariffs or FX impacts. - Agneta Palmer, CFO
Q: How is the demand for ventilators expected to evolve, and can you disclose the number of ventilators you anticipate selling this year? A: Ventilator demand remains strong, but we expect more challenging comparisons in the second half of the year. We do not disclose specific sales numbers for ventilators. - Mattias Perjos, CEO
Q: Could you provide more details on the tariff payments and their regional impact? A: Tariff payments began in the second half of April, primarily affecting EU to US flows. We have taken measures to manage our supply chain in response to these tariffs. - Agneta Palmer, CFO
Q: What is driving the positive development of Paragonix, and can you provide any margin details? A: The margin expansion for Paragonix is volume-driven, and it is now accretive to group margins. The growth is supported by a successful product portfolio, including the KidneyVault launch. - Mattias Perjos, CEO
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.
Inicia sesión para acceder a tu portafolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Capital Clean Energy Carriers Corp. Schedules Second Quarter 2025 Earnings Release, Conference Call and Webcast
ATHENS, Greece, July 28, 2025 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) today announced that before the NASDAQ market opens on July 31, 2025, CCEC will release financial results for the second quarter ended June 30, 2025. On the same day, Thursday, July 31, 2025, CCEC will host an interactive conference call at 8:00 a.m. Eastern Time to discuss the financial results. Conference Call Details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In). Please quote 'Capital Clean Energy' to the operator and/or conference ID 13754092. Click here for additional participant International Toll-Free access numbers. Alternatively, participants can register for the call using the call me option for a faster connection to join the conference call. You can enter your phone number and let the system call you right away. Click here for the call me option. Slides and Audio Webcast There will also be a live, and then archived, webcast of the conference call and accompanying slides, available through the Company's website. To listen to the archived audio file, visit our website and click on Webcasts & Presentations under our Investor Relations page. Participants to the live webcast should register on the website approximately 10 minutes prior to the start of the webcast. Add to CalendarTo easily add this event to your calendar, please use the following links: Outlook | Google Calendar About Capital Clean Energy Carriers Corp. Capital Clean Energy Carriers Corp. (NASDAQ: CCEC), an international shipping company, is one of the world's leading platforms of gas carriage solutions with a focus on energy transition. CCEC's in-the-water fleet includes 15 high specification vessels, including 12 latest generation LNG/Cs and three legacy Neo-Panamax container vessels. In addition, CCEC's under-construction fleet includes six additional latest generation LNG/Cs, six dual-fuel medium gas carriers and four handy LCO2/multi-gas carriers, to be delivered between the first quarter of 2026 and the third quarter of 2027. For more information about CCEC, please visit Contact Details: Investor Relations / MediaBrian GallagherEVP Investor RelationsTel. +44-(770) 368 4996E-mail: Nicolas Bornozis/ Markella Kara Capital Link, Inc. (New York) Tel. +1-212-661-7566E-mail: ccec@ in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
US and China officials meet in Stockholm to discuss how to ease trade tensions
STOCKHOLM, Sweden (AP) — Top trade officials from China and the United States arrived for a new round of talks in Stockholm on Monday in a bid to ease tensions over trade between the world's two biggest national economies. U.S. Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng were meeting at the offices of Sweden's prime minister for talks that Bessent has said will likely to lead to an extension of current tariff levels. Analysts say the two envoys could set the stage for a possible meeting between U.S. President Donald Trump and Chinese President Xi Jinping later this year to cement a recent thaw in trade tensions. The talks are the third this year between He and Bessent — nearly four months after Trump upended global trade with his sweeping tariff proposals, including an import tax that shot up to 145% on Chinese goods. China quickly retaliated, sending global financial markets into a temporary tailspin. The Stockholm meeting — following similar talks in Geneva and London in recent months — is set to extend a 90-day pause on those tariffs. During the pause, U.S. tariffs were lowered to 30% on Chinese goods, and China set a 10% tariff on U.S. products. The Trump administration, fresh off a deal on tariffs with the European Union, wants to reduce a trade deficit that came in at $904 billion overall last year — including a nearly $300 billion trade deficit with China alone. China's Commerce Ministry, for its part, said last week that Beijing wants 'more consensus and cooperation and less misperception' from the Stockholm talks. —— Didi Tang and Josh Boak in Washington contributed to this report. Solve the daily Crossword
Yahoo
21 minutes ago
- Yahoo
Oppenheimer lifts S&P 500 year-end target to Wall Street-high on trade optimism
(Reuters) -Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major Wall Street brokerages, betting on easing trade tensions and strong corporate earnings. Its current target implies an 11.13% upside to the benchmark index's last close of 6,388.64. Oppenheimer previously set a target of 5,950 for the index. "With the announcement of trade deals (Japan, EU) by President Trump... we believe that enough 'tariff hurdles' have been overcome for now," Oppenheimer strategists led by John Stoltzfus said in a note. The U.S. and European Union finalised a trade deal on Sunday, that sets a 15% tariff on most European goods including cars, semiconductors and pharmaceuticals, while the EU pledged to buy $750 billion in U.S. energy and invest $600 billion in the U.S. economy. Last week, U.S. President Donald Trump struck a $550 billion deal with Japan. Earlier this month, Goldman Sachs, Bank of America, and RBC Capital Markets also raised their S&P 500 targets The S&P 500 has rebounded 28.2% since its April 8 low, following Trump's 'Liberation Day' tariffs, broadly driven by cyclical sectors such as technology, industrials and communication services. Oppenheimer brought back its S&P 500 earnings estimate to $275, which it had originally set in December 2024, having trimmed its projection to $265 in April. Stoltzfus continues to favor U.S. equities, particularly cyclical stocks, and sees further upside as inflation moderates and expects the Federal Reserve to hold interest rates steady in this week's policy meeting.
